|
"su tung hung"的相關文件
顯示項目 56-80 / 133 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2016 |
Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice
|
Lin, Wei-Hsiang; Yeh, Shiou-Hwei; Yeh, Kun-Huei; Chen, Kai-Wei; Cheng, Ya-Wen; Su, Tung-Hung; Jao, Ping; Ni, Lin-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 葉坤輝; 葉秀慧; 陳培哲 |
| 國立臺灣大學 |
2016 |
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-kappa B signaling and tumor progression in a woodchuck hepatocellular carcinoma model
|
Li, Yung-Tsung; Liu, Chun-Jen; Su, Tung-Hung; Cheng, Huei-Ru; Jeng, Yung-Ming; Lin, Hsiu-Lin; Wang, Chih-Chiang; Kao, Jia-Horng; Chen, Pei-Jer; Chen, Ding-Shinn; Wu, Hui-Lin; 陳定信; 高嘉宏; 鄭永銘; 吳慧琳; 蘇東弘; 劉俊人; 陳培哲; 林琇玲 |
| 國立臺灣大學 |
2016 |
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis
|
Yang, Hwai-I; Tseng, Tai-Chung; Liu, Jessica; Lee, Mei-Hsuan; Liu, Chun-Jen; Su, Tung-Hung; Batrla-Utermann, Richard; Chan, Henry Lik-Yuen; Kao, Jia-Horng; Chen, Chien-Jen; 陳建仁; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2016 |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Hepatitis C Virus and Lymphoma REPLY
|
Su, Tung-Hung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Hepatitis C Viral Infection Increases the Risk of Lymphoid-Neoplasms: A Population-Based Cohort Study
|
Su, Tung-Hung; Liu, Chun-Jen; Tseng, Tai-Chung; Chou, Shih-Wan; Liu, Chen-Hua; Yang, Hung-Chih; Wu, Shang-Ju; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Chi-Ling; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 吳尚儒; 陳祈玲 |
| 國立臺灣大學 |
2016 |
Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus
|
Su, Tung-Hung; Liu, Chun-Jen; Shu, Pei-Yun; Fu, Yang-Hsien; Chang, Chi-Hsien; Jao, Ping; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 劉俊人 |
| 國立臺灣大學 |
2016 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Hung-Chih; Chen, Chi-Ling; Yang, Wan-Ting; Tsai, Cheng-Shiue; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
|
Liu, Chen-Hua; Liu, Chun-Jen; Huang, Chung-Feng; Lin, Jou-Wei; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Meng-Kun; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 李志元; 劉俊人; 陳世宜; 陳培哲; 蔡孟昆; 林昭維; 蔡宏斌 |
| 國立臺灣大學 |
2015 |
Advanced Hepatic Fibrosis and Steatosis Are Associated With Persistent Alanine Aminotransferase Elevation in Chronic Hepatitis C Patients Negative for Hepatitis C Virus RNA During Pegylated Interferon Plus Ribavirin Therapy
|
Liang, Cheng-Chao; Liu, Chen-Hua; Chung, Chen-Shuan; Lin, Cheng-Kuan; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Peginterferon plus weight-based ribavirin for treatment-naive hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy
|
Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Serum viral load is not the major determinant of hepatocellular carcinoma risk in chronic hepatitis B patients with compensated liver cirrhosis
|
Tseng, Tai-Chung; Liu, Chun-Jen; Yang, Wan-Ting; Yang, Hung-Chih; Chen, Chi-Ling; Su, Tung-Hung; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naive Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua; Huang, Chung-Feng; Liu, Chun-Jen; Dai, Chia-Yen; Huang, Jee-Fu; Lin, Jou-Wei; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 國立臺灣大學 |
2015 |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
|
Liu, Chen-Hua; Sheng, Wang-Hui; Sun, Hsin-Yun; Hsieh, Szu-Min; Lo, Yi-Chun; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Liu, Wen-Chun; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 孫幸筠; 劉俊人; 謝思民; 陳培哲; 盛望徽; 洪健清 |
| 國立臺灣大學 |
2015 |
分子標靶治療藥物在肝纖維化進展之療效
|
蘇東弘; Su, Tung-Hung |
| 國立臺灣大學 |
2015 |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, Tung-Hung; Shiau, Chung-Wai; Jao, Ping; Liu, Chen-Hua; Liu, Chun-Jen; Tai, Wei-Tien; Jeng, Yung-Ming; Yang, Hung-Chih; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 鄭永銘; 楊宏志; 蘇東弘; 陳昆鋒; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng, Huei-Ru; Kao, Jia-Horng; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Yang, Hung-Chih; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
Improving clinical outcomes of chronic hepatitis B virus infection
|
Su, Tung-Hung; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, Chih-Lin; Liu, Chen-Hua; Wang, Chia-Chi; Liang, Cheng-Chao; Su, Tung-Hung; Liu, Chun-Jen; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人 |
顯示項目 56-80 / 133 (共6頁)
<< < 1 2 3 4 5 6 > >>
每頁顯示[10|25|50]項目
|
